| Product Code: ETC5242405 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Netherlands continues to be a key destination for aminoglycosides import shipments, with top exporters in 2024 being China, USA, Italy, Belgium, and India. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, with a notable compound annual growth rate (CAGR) of 34.79% from 2020 to 2024. However, a slight decline is seen in the growth rate from 2023 to 2024 at -22.49%, suggesting a potential shift in market dynamics. Monitoring these trends will be crucial for stakeholders in the aminoglycosides import market in the Netherlands.

By 2027, the Aminoglycosides market in Netherlands is anticipated to reach a growth rate of 0.00%, as part of an increasingly competitive Europe region, where Germany remains at the forefront, supported by United Kingdom, France, Italy and Russia, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Aminoglycosides Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Aminoglycosides Market - Industry Life Cycle |
3.4 Netherlands Aminoglycosides Market - Porter's Five Forces |
3.5 Netherlands Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Netherlands Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Netherlands Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in the Netherlands |
4.2.2 Growing demand for aminoglycosides due to their effectiveness in treating various infections |
4.2.3 Technological advancements in aminoglycoside drug formulations |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and commercialization of aminoglycoside drugs in the Netherlands |
4.3.2 Rising concerns about antibiotic resistance leading to potential limitations on aminoglycoside usage |
5 Netherlands Aminoglycosides Market Trends |
6 Netherlands Aminoglycosides Market Segmentations |
6.1 Netherlands Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.3 Netherlands Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.4 Netherlands Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.5 Netherlands Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.6 Netherlands Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.7 Netherlands Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Netherlands Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Netherlands Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Netherlands Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Netherlands Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Netherlands Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Netherlands Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Netherlands Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Netherlands Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Netherlands Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Netherlands Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Netherlands Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Netherlands Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Netherlands Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Netherlands Aminoglycosides Market Import-Export Trade Statistics |
7.1 Netherlands Aminoglycosides Market Export to Major Countries |
7.2 Netherlands Aminoglycosides Market Imports from Major Countries |
8 Netherlands Aminoglycosides Market Key Performance Indicators |
8.1 Research and development investment in aminoglycoside drug development |
8.2 Adoption rate of newer aminoglycoside formulations in the market |
8.3 Number of partnerships and collaborations for the development and commercialization of aminoglycoside drugs |
9 Netherlands Aminoglycosides Market - Opportunity Assessment |
9.1 Netherlands Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Netherlands Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Netherlands Aminoglycosides Market - Competitive Landscape |
10.1 Netherlands Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |